Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
FOXO4-DRI FOXO4-DRI is a senolytic peptide designed to selectively induce apoptosis in senescent cells by disrupting the FOXO4-p53 interaction
It is licensed for use in T2D as an add-on therapy to metformin, sulphonylureas, pioglitozone or long-acting insulin only
Reconstitution, Storage & Handling Protocols All CoreVionRX peptides ship as sterile lyophilized powder
Long-Term Cost Considerations While the first month may come with substantial discounts, it is important to consider the long-term costs associated with the subscription
US$ 20.35
US$ 27.17
US$ 28.09
